Tetsushi Furukawa Selected Research

Tetsushi Furukawa Research Topics

Disease

8	Cardiac Arrhythmias (Arrythmia) 10/2022 - 07/2007
5	Atrial Fibrillation 01/2021 - 08/2017
4	Torsades de Pointes (Torsade de Pointes) 01/2011 - 09/2005
3	Heart Diseases (Heart Disease) 09/2012 - 07/2007
2	Inflammation (Inflammations) 01/2021 - 11/2020
2	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 11/2019 - 11/2014
2	Bradycardia 01/2019 - 01/2015
2	Long QT Syndrome 09/2012 - 12/2007
2	Reperfusion Injury 12/2006 - 06/2004
2	Cardiomegaly (Heart Hypertrophy) 11/2006 - 06/2002
1	Infarction (Infarctions) 01/2022
1	Myocardial Infarction 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Tachycardia (Tachyarrhythmias) 01/2018
1	Andersen Syndrome 03/2017
1	Polymorphic catecholergic ventricular tachycardia 08/2016
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 05/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Cardiotoxicity 05/2015
1	Hypertrophy 11/2014
1	Short Qt Syndrome 01/2013
1	Pain (Aches) 04/2009
1	Seizures (Absence Seizure) 04/2009
1	Neoplasms (Cancer) 04/2009
1	Ischemia 12/2006
1	Sudden Death 11/2006
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 02/2004

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 01/2018 - 09/2005
5	Ion Channels (Ion Channel)IBA 05/2015 - 06/2002
2	CytokinesIBA 11/2020 - 01/2016
2	Potassium Channels (Potassium Channel)IBA 01/2019 - 11/2006
2	Transcription Factors (Transcription Factor)IBA 08/2017 - 05/2016
2	Hormones (Hormone)IBA 01/2010 - 03/2009
2	Progesterone FDA LinkGeneric 01/2010 - 12/2007
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2010 - 07/2007
2	ginsenoside ReIBA 12/2006 - 06/2004
2	Messenger RNA (mRNA)IBA 11/2006 - 06/2002
1	ChemokinesIBA 01/2022
1	Durapatite (Hydroxylapatite)IBA 01/2022
1	LigandsIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2022
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2021
1	ConnectinIBA 11/2019
1	NIP 151IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Flecainide (Tambocor)FDA LinkGeneric 03/2017
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 08/2016
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 05/2016
1	Proteins (Proteins, Gene)FDA Link 05/2016
1	Sodium Channel BlockersIBA 01/2015
1	Endothelin-1 (Endothelin 1)IBA 11/2014
1	Ether (Diethyl Ether)IBA 01/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Testosterone (Sustanon)FDA Link 01/2010
1	Steroid Receptors (Steroid Receptor)IBA 12/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006
1	Phytosterols (Plant Sterols)IBA 12/2006
1	Protein AggregatesIBA 02/2004
1	Keratin-14 (Keratin 14)IBA 02/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2004
1	Angiotensin Receptor AntagonistsIBA 06/2002
1	Amlodipine (Norvasc)FDA LinkGeneric 06/2002
1	candesartanIBA 06/2002

Therapy/Procedure

2	Therapeutics 01/2015 - 09/2012
1	Drug Therapy (Chemotherapy) 10/2022
1	Ligation 01/2022
1	Catheter Ablation 10/2017